17 articles
Corteva completed the spin-off of its seed and genetics business, Vylor, on October 1, remaining as a standalone crop protection company focused on biologicals and cost reductions.
Corteva spun off its seed business into Vylor to concentrate on crop protection, aiming for $1 billion in biologicals sales by 2030. This move aligns with broader industry reshaping by competitors lik
Corteva and Globachem announced plans to establish a joint venture for plant protection products, expected to launch in the early 2030s following regulatory approval and deal closure in Q4 2026.
A coalition of US states seeks to block Corteva's planned corporate split, alleging it would shield assets from PFAS liability claims. Corteva denies the accusations, calling the move a legitimate bus
Corteva CEO Luther Kissam advocates for the continued use of crop protection chemicals despite political opposition and market volatility. As the company separates from its seed business, it focuses o
The American Chemical Society honored industry leaders from Corteva, Gilead, Novartis, and Qnity Electronics as 2026 Heroes of Chemistry during its Fall meeting, marking the program's 30th anniversary
Vylor Inc. is issuing high-grade debt to finance a distribution to parent Corteva ahead of its October spinoff completion. Corteva, a top global supplier of GM seeds and crop protection chemicals, und
California Attorney General alleges DuPont and its spin-offs restructured to shift PFAS liabilities onto Chemours while limiting exposure for Corteva and New DuPont. The legal filing claims an MOU was
Corteva raised its 2026 financial outlook citing seed segment strength that offset crop protection pressures, reporting higher adjusted EPS and EBITDA. The agtech firm confirmed plans to spin off its
Corteva raised its full-year profit outlook based on strong crop market demand. However, shares fell 3.7% after missing Q2 revenue estimates amid shifting acreage toward soybeans and high input costs.
FMC and Corteva signed a deal expanding access to FMC's rimisoxafen herbicide technology across the Americas, with Corteva paying $200 million for active ingredient supply to manage resistant weeds in
The European Parliament approved a new regulatory framework enabling the cultivation of gene-edited crops, marking a major shift from restrictive GMO rules. Implementation begins in mid-2028 following
Corteva anticipates total pre-tax restructuring charges of $750 million to $815 million, including a planned exit from its Asturias, Spain crop protection site. The move aims to streamline global manu
Corteva Inc. appointed Luke Kissam as CEO for its future separate crop protection business, scheduled to spin off in Q4 2026. The full executive leadership team was revealed ahead of an investor day o
Corteva reported a 31% year-over-year drop in Q4 adjusted EPS to 22 cents, driven by a 5% sales volume decline despite a 1% price increase.
Global agrochemical markets are projected to grow to $77.7 billion in 2026 despite cost pressures and tariff uncertainties. Industry leaders like Corteva and BASF are restructuring operations while re
Corteva and BP launched a 50-50 joint venture, Etlas, to produce crop oil feedstocks for sustainable aviation fuel and renewable diesel. Targeting 1 million tons of annual raw material capacity by the
ChemBrief